六月 2026
- Home
- Cobra Biologics
六月 2026的Cobra Biologics市场份额分析
charles river provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.
Cobra Biologics(包含公司地区分支机构)
查看更多网站流量和参与度信息- cobrabio.com
Cobra Biologics收入截至 六月 2026为 25M - 50M
Cobra Biologics主要域名产生的收入
3 年中Cobra Biologics主要域名的收入
Cobra Biologics主要域名的收入
Cobra Biologics热门域名的总访问量
了解Cobra Biologics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
无数据可显示
无数据可显示
Cobra Biologics热门域名的平均访问时长
分析Cobra Biologics参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
Cobra Biologics热门域名的平均页面浏览量
了解Cobra Biologics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
无数据可显示
无数据可显示
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Cobra Biologics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Charles River Chamber acquires Cobrabio.She said that Cobra Biologics, which was “a key part of the early scale for the vaccine manufacturing”, has been acquired by American pharmaceutical company Charles River.
十一月 30, 2022阅读更多
新闻Charles River Laboratories International, Inc. acquired Cobrabio on Jan 1st '21.The expansion follows Charles River’s acquisition of Keele, England-based Cobra Biologics, a plasmid DNA and viral vector cell and gene therapy contract development and manufacturing organisation (CDMO), in March 2021 and will see an additional 50 new positions created, from apprentices through to experienced scientists.
三月 7, 2022阅读更多
新闻Charlesriver acquired Cobrabio on Mar 1st '21.The expansion follows Charles River’s acquisition of Keele-based Cobra Biologics, a pioneering plasmid DNA and viral vector cell and gene therapy contract development and manufacturing organisation (CDMO), in March 2021 and will see an additional 50 new positions created, from apprentices through to experienced scientists.
二月 24, 2022阅读更多
查看 Cobra Biologics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
